77 Corporate Drive in Bridgewater — Courtesy: Cushman & Wakefield
By Joshua Burd
The owner of a 210,000-square-foot office building in Bridgewater is making a push to attract life sciences companies, having already secured one such lease in recent months.
According to Cushman & Wakefield, the new leasing agent at 77 Corporate Drive, Legacy Investing has repositioned the building for that very purpose. The team noted that a Fortune 500 global life science company recently signed a lease at the building off Route 206 and interstates 78 and 287, although they did not disclose the tenant’s name or the size of the deal.
Outside market reports note that Avantor, which provides products and services to customers in biopharma, health care, education and other sectors, took 59,096 square feet at the property during the second quarter.
“As demand for life sciences in the New Jersey market continues to increase, we are excited to have repositioned this trophy office asset into a life sciences hub, providing new Class A space for the many life sciences tenants in the area,” Legacy Investing’s Daniel English said. “By leveraging the expertise of Cushman & Wakefield’s New Jersey Life Sciences Practice Group, we are confident we will lease up this premier building and make our mark in New Jersey’s thriving life sciences market.”
The Cushman team includes Shawn Straka, Todd Elfand and Charles Parmelli. They noted that CBRE represented the landlord and RV3 Solutions represented the tenant in the earlier deal.
“This is one of the first Class A office buildings in the New Jersey market that has been repurposed into a life sciences property,” Straka said. “Legacy Investing is a best-in-class, technically adept landlord that works with tenants to create a top-tier work environment. 77 Corporate Drive is a trophy asset with strong infrastructure and fully redundant power. The New Jersey life sciences market is very active, and we are thrilled to be leasing the building on behalf of Legacy Investing.”
